ALCSI Summit 2026

July 10–12, 2026

Boston, Massachusetts

Explore the full agenda
Participants and programming at the 2026 ALCSI Summit

Learning together.
Taking action.

The 2026 ALCSI Summit brought together students from across the nation for an enriching 3-day program featuring lectures from leaders in medicine and public health, as well as immersive programming focused on lung cancer screening, community engagement, advocacy, and leadership development.

Inside the program

  • Guest lectures from leading researchers and physicians in the lung cancer field
  • A lung cancer patient panel
  • Clinical teaching sessions
  • Leadership development workshops focused on community outreach and ALCSI initiatives
  • College, pre-medical, and medical school application workshops from undergrad students, medical students, and faculty at leading institutions, including Harvard College and Harvard Medical School
  • Presentations on innovations and community advocacy projects by ALCSI Innovation Challenge Finalists.
Sessions, speakers & times

Featured speakers

Moments from 2026

Conversations, connections, and community.

Participants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI SummitParticipants and programming at the 2026 ALCSI Summit

Our sponsors

AstraZenecaLillyRazor Genomics

See you in 2027.

July 9–11, 2027 · Boston, Massachusetts

The next ALCSI Summit
Dr. Anthony S. Fauci

Dr. Anthony S. Fauci

Dr. Anthony S. Fauci is the former Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health, a position he held for nearly four decades from 1984 to 2022, and former Director of the NIAID Laboratory of Immunoregulation. He advised seven U.S. Presidents, from Ronald Reagan through Joe Biden, and served as Chief Medical Advisor to President Biden. He is a Member of the National Academy of Medicine and a recipient of the Presidential Medal of Freedom , among the most prestigious honors in American public life. As principal architect of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), he played a foundational role in reshaping the global response to infectious disease. Over the course of his career, he amassed an h-index of 242 and more than 298,000 citations , placing him among the most cited biomedical researchers in history, with publications in the New England Journal of Medicine , JAMA , Cell , Science , and the Proceedings of the National Academy of Sciences.
Dr. Jessica S. Donington

Dr. Jessica S. Donington

Dr. Jessica S. Donington is a Professor of Surgery, Chief of Thoracic Surgery, and Director of Lung Cancer Screening at the University of Chicago. She has expertise in multimodal therapy for locally advanced lung cancer, lung cancer clinical trials, and treatment for medically high-risk patients with early-stage lung cancer. She serves as Surgical Chair of the NRG Oncology Lung Group and Co-Chair of the National Cancer Institute Thoracic Malignancies Steering Committee. Dr. Donington is a past president of Women in Thoracic Surgery, the New York Society for Thoracic Surgery, and the Western Thoracic Surgical Association. She was recently elected Second Vice-President of the Society of Thoracic Surgeons (STS) and will assume the role of STS President in January 2028. She also serves on the editorial boards of the Annals of Thoracic Surgery , the Journal of Thoracic Oncology , and CHEST . She was recently named the recipient of the prestigious 2025 Nina Starr Braunwald Extraordinary Woman in Cardiothoracic Surgery.
Dr. Lecia V. Sequist

Dr. Lecia V. Sequist

Dr. Lecia V. Sequist is the Landry Family Professor of Medicine in the Field of Medical Oncology at Harvard Medical School and the Director of the Cancer Early Detection and Diagnostics Program at Mass General Brigham Cancer Institute , where she has been a faculty member since 2005. An attending thoracic medical oncologist with expertise in EGFR-targeted therapies and early cancer detection, she has held research grants from the National Institutes of Health, the Department of Defense, Stand Up to Cancer, and numerous private foundations. She is the co-senior author of the landmark deep-learning study introducing Sybil (a convolutional neural network capable of predicting six-year lung cancer risk from a single low-dose CT scan) published in the Journal of Clinical Oncology , and has published in the New England Journal of Medicine , among other top-tier journals. She co-leads the Cancer Risk, Prevention and Early Detection Program at the Dana-Farber/Harvard Cancer Center and serves on the Scientific Advisory Committee of Stand Up to Cancer.
Dr. Elsie M. Taveras

Dr. Elsie M. Taveras

Elsie Taveras, MD, MPH, is the inaugural Chief Community Health and Equity Officer at Mass General Brigham and Executive Director of the Kraft Center for Community Health at Massachusetts General Hospital . She leads system-wide strategies to improve health equity and the health of the communities served by Mass General Brigham. She is a pediatrician at Mass General, the Conrad Taff Professor of Pediatrics in Nutrition at Harvard Medical School and professor in the Department of Nutrition at Harvard T.H. Chan School of Public Health. Dr. Taveras is a leading expert in community health equity, childhood obesity, maternal-child health and health disparities. Her research and community health leadership have influenced the development of national programs to improve health outcomes and eliminate inequities for socially at-risk populations. She is a recipient of the Public Health Leadership in Medicine Award from the Massachusetts Association of Public Health for her work improving health and health care in community-based settings.
Dr. Nancy E. Oriol

Dr. Nancy E. Oriol

Dr. Nancy E. Oriol is former Dean of Students at Harvard Medical School and current Faculty Associate Dean for Community Engagement in Medical Education at Harvard Medical School. Her work focuses on advancing health equity, community-based healthcare delivery, and medical education through innovative programs such as the Family Van, a mobile health clinic that has provided thousands of health and social service visits annually for more than three decades. She also co-founded HMS MEDscience , an innovative simulation-based science curriculum designed to address educational achievement gaps and inspire future healthcare professionals, and is the inventor of two medical devices . Dr. Oriol has received numerous honors for her career of service to patients, students, and communities, including the American Medical Association’s Dr. Louis W. Sullivan Award, the Pride of the Profession Award, the Dean’s Community Service Lifetime Achievement Award, and the Gold Foundation’s Pearl Hurwitz Award for Humanism in Healthcare.
Dr. Stephen C. Yang

Dr. Stephen C. Yang

Dr. Stephen C. Yang is a Professor of Surgery and Medical Oncology at Johns Hopkins University School of Medicine and The Johns Hopkins Hospital, and the inaugural recipient of the Arthur B. and Patricia B. Modell Professor in Thoracic Surgery, the first endowed chair of its kind at Johns Hopkins . A board-certified thoracic surgeon with expertise in lung cancer, esophageal cancer, mesothelioma, robotic surgery, and minimally invasive procedures, he also completed a three-year thoracic surgical oncology research fellowship at the University of Texas M.D. Anderson Cancer Center. He serves as Chair of the Maintenance of Certification Committee and as a Director of the American Board of Thoracic Surgery , as Chair of the Committee on Medical Student Education for the American College of Surgeons, and as Editor-in-Chief of the S ESATS XIII Review . He is the Editor of Practical Reviews in Chest Medicine and serves as co-editor of Current Therapy in Thoracic and Cardiovascular Surgery and series editor-in-chief of The Early Diagnosis of Cancer .
Dr. Anthony V. D'Amico

Dr. Anthony V. D'Amico

Dr. Anthony V. D'Amico is the Eleanor Theresa Walters Endowed Chair in Radiation Oncology and is a Professor of Radiation Oncology at Harvard Medical School. He serves as Chief of the Division of Genitourinary Radiation Oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute. He earned his Ph.D. in Radiation Physics from the Massachusetts Institute of Technology in 1986 and his M.D. from the University of Pennsylvania in 1990, where he later served as chief resident. His research (focused on the detection, risk stratification, staging, and treatment of prostate cancer, including the development of widely used PSA-based risk classification criteria that have shaped national treatment guidelines) has been funded by federal grants from the NIH, the National Cancer Institute, the Department of Defense, and the Massachusetts Department of Public Health. He has authored more than 140 peer-reviewed publications , with a research portfolio totaling over 750 works and more than 41,000 citations , including studies published in the Journal of Clinical Oncology , the Journal of Urology , and JAMA . He has co-edited four textbooks in Urologic Oncology and continues to lead independent laboratory research into the biology of prostate-specific antigen and benign-malignant prostatic cell interactions.
Dr. Drew Moghanaki

Dr. Drew Moghanaki

Dr. Drew Moghanaki is a Professor and Chief of Thoracic Oncology in the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research. He holds a joint appointment in the Veterans Health Administration, where he directs lung cancer care and research at the Greater Los Angeles VA Medical Center and co-directs the VA Greater Los Angeles Lung Precision Oncology Program. He is the principal co-investigator and co-chair of the VALOR trial, a phase III randomized clinical trial , sponsored by the VA Cooperative Studies Program, comparing surgical resection to stereotactic body radiation therapy (SBRT) in operable stage I non-small cell lung cancer. He leads the VA Partnership to Increase Access to Lung Screening (VA-PALS) and the California Partnership to Increase Access to Lung Screening (CAL-PALS), and his cumulative research portfolio exceeds $60 million in lung cancer early detection and clinical trial funding. He has published in JAMA , the Journal of Clinical Oncology , and other top journals, and in 2025 was inducted as a Fellow of the American Society for Radiation Oncology (ASTRO).
Dr. Chi-Fu Jeffrey Yang

Dr. Chi-Fu Jeffrey Yang

Dr. Chi-Fu Jeffrey Yang is a thoracic surgeon at Massachusetts General Hospital, Associate Professor of Surgery at Harvard Medical School, and Director of Research and Infrastructure for the Mass General Brigham Division of Thoracic Surgery. He practices all aspects of thoracic surgery, including procedures for conditions of the lung and mediastinum, and specializes in minimally invasive techniques. He is the Founding Director of the Center for Artificial Intelligence and Innovation Research (CAIIRE) at MGH, the Founder and Chair of the American Lung Cancer Screening Initiative (ALCSI), and the current President of the Thoracic Outcomes Research Network (ThORN). He serves as principal investigator (or co-PI) and project leader on multiple NIH-funded grants, including an R01, R18, and R21 , and leads a research portfolio totaling approximately $15 million. He has senior-authored studies in JAMA , Journal of Clinical Oncology , British Medical Journal , Annals of Surgery and other top journals. He is an exceptional mentor to our ALCSI team and surgical residents and fellows, and has received several distinguished teaching awards including the Harvard Medical School Charles McCabe Faculty Prize for Excellence in Teaching and the Harvard Medical School Young Mentor Award.
Dr. Narjust Florez

Dr. Narjust Florez

Dr. Narjust Florez is a thoracic medical oncologist at Dana-Farber Cancer Institute, an Assistant Professor of Medicine at Harvard Medical School , Associate Editor at the New England Journal of Medicine Clinician and JAMA Oncology , and the Associate Director of the Cancer Care Equity Program at Dana-Farber/Harvard Cancer Center . She serves as principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study , the largest study to date examining sexual dysfunction in women with lung cancer, and the EQUAL Study evaluating a blood-based test for EGFR-positive lung cancer in Hispanic and East Asian communities. Dr. Florez is a member of the board of directors for the International Association for the Study of Lung Cancer (IASLC) board. She also co-hosts Lung Cancer Considered , which is the flagship podcast of the IASLC available around the world in more than 20 languages. In 2024, she was selected as the youngest Fellow of the American Society of Clinical Oncology.
Dr. Jules Lin

Dr. Jules Lin

Dr. Jules Lin is a Professor of Thoracic Surgery at the University of Michigan Medical School and the inaugural Mark B. Orringer Research Professor of Surgery , a named chair honoring the pioneering thoracic surgeon under whom the University of Michigan became a world leader in esophageal surgery. He currently serves as Associate Chief Clinical Officer for Cardiovascular and Neurological Surgery and as Surgical Director of the Lung Transplant Program at University of Michigan Health, where he specializes in lung and esophageal cancer, minimally invasive and robotic thoracic surgery, tracheobronchial resection and reconstruction, and lung transplantation. He is a member of the National Comprehensive Cancer Network (NCCN) Non-Small Cell Lung Cancer Panel , contributing to the development of national clinical practice guidelines, and serves on the American College of Surgeons Surgical Standards Manual Lung Group . He received his medical degree from Harvard Medical School and completed his general surgery residency and thoracic research fellowship at the University of Michigan. His research has been published in the Journal of Thoracic and Cardiovascular Surgery and other leading thoracic surgery journals.
Dr. Priya Gupta

Dr. Priya Gupta

Dr. Priya Sarin Gupta is a primary care physician at the MGH Charlestown Health Care Center, an Instructor in Medicine at Harvard Medical School, and the Senior Medical Director for Mobile Health Services at the MGH Kraft Center for Community Health. In this role, she leads the MGB Community Care Vans program, directing mobile health outreach that brings preventive care (including lung cancer screening education and navigation) directly to underserved communities across Greater Boston. She completed her fellowship in Adolescent and Young Adult Medicine at Johns Hopkins University, her residency in Family Medicine at Brown University, and holds a Master of Public Health with a focus on the social determinants of health disparities from Columbia University. Her research and clinical work center on health equity, mobile health delivery, and eliminating barriers to preventive care for historically marginalized populations.